Russell Investments Group Ltd. Has $2.28 Million Stock Position in OraSure Technologies, Inc. $OSUR

Russell Investments Group Ltd. increased its position in shares of OraSure Technologies, Inc. (NASDAQ:OSUR) by 111.1% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 676,334 shares of the medical instruments supplier’s stock after purchasing an additional 355,915 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.87% of OraSure Technologies worth $2,279,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the company. Tower Research Capital LLC TRC increased its stake in shares of OraSure Technologies by 202.3% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,821 shares of the medical instruments supplier’s stock valued at $28,000 after buying an additional 5,234 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in shares of OraSure Technologies in the fourth quarter valued at $37,000. Boothbay Fund Management LLC acquired a new stake in shares of OraSure Technologies in the fourth quarter valued at $42,000. Gotham Asset Management LLC acquired a new stake in shares of OraSure Technologies in the fourth quarter valued at $43,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of OraSure Technologies in the first quarter valued at $49,000. Institutional investors and hedge funds own 93.50% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently weighed in on OSUR shares. Evercore ISI restated an “in-line” rating and issued a $3.00 target price on shares of OraSure Technologies in a research note on Monday, May 19th. Wall Street Zen upgraded OraSure Technologies from a “sell” rating to a “hold” rating in a research note on Saturday, May 17th. One analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $3.00.

OraSure Technologies Stock Up 4.7%

OraSure Technologies stock opened at $3.14 on Tuesday. The business’s 50-day simple moving average is $3.03 and its 200 day simple moving average is $3.11. The stock has a market cap of $229.65 million, a price-to-earnings ratio of -4.69 and a beta of 0.27. OraSure Technologies, Inc. has a 12-month low of $2.36 and a 12-month high of $4.61.

About OraSure Technologies

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company’s products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.